Skip to content

Can Kangarooing Small Babies on the Back of a Mother Keep Them Warm and Stable

The Effect of Chest-to-Back Skin-to-Skin Contact on Regulation of Physiological Parameters for Low Birth Weight and/or Premature Infants: a Crossover Randomized Controlled Clinical Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04346498
Enrollment
50
Registered
2020-04-15
Start date
2017-01-03
Completion date
2019-10-14
Last updated
2020-04-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Body Temperature, Heart Rate, Oxygen Saturation, Respiratory Rate, Sleep Pattern

Brief summary

The purpose of this study was to assess the effectiveness of Kangarooing small babies on the back of a mother

Detailed description

After the study was explained (risks and benefits) and written informed consent was received from participants, an individually controlled randomized crossover clinical trial was conducted to examine the effectiveness of Chest-to-Back (CB) skin-to-skin contact (SSC) compared with the standard. The trial was done in accordance with the protocol, good clinical practice, and the national regulatory and ethics guideline of Ethiopia (which is in line with the Helsinki declaration).

Interventions

OTHERChest-to-back

Sponsors

Arsi University
CollaboratorOTHER
Adds Continental Institute of Public Health
CollaboratorUNKNOWN
SISAY GERE
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Masking description

Mothers were masked only for the presence or absence of a sequence in the trial. Hospital staffs, students, and investigators of the study were all blinded to allocation of the intervention. Until the study was finalized, access to the database was restricted to the data manager only

Eligibility

Sex/Gender
ALL
Age
1 Days to 28 Days
Healthy volunteers
No

Inclusion criteria

* Neonates with LBW (\<2500 grams) * Born prematurely (\< 37 complete weeks of gestation)

Exclusion criteria

* less than 35 weeks of gestation on the day of enrollment to trial * Malformations or birth disabilities * Dependent on oxygen or IV fluid * Any disorder that was deemed necessary for exclusion by the investigator.

Design outcomes

Primary

MeasureTime frameDescription
Change in skin temperature from baseline: From the start of SSC (0 hour) to end of SSC (2 hours) per day, assessed for three consecutive daysSkin temperature values were recorded every 10 minutes. Including the baseline, the 2 hours intervention would provide 13 measurements. A participant who successfully completed the intervention would have78 measurements; 39 for the treatment arm and 39 for the control arm.

Other

MeasureTime frameDescription
Change from baseline in peripheral arterial oxygen saturation on SCRIP ScoreFrom the start of SSC (0 hour) to end of SSC (2 hours) per day, assessed for three consecutive daysStability of the cardio-respiratory system in premature infants (SCRIP) score is a reliable instrument for determining the stability of oxygen saturation (i.e., peripheral arterial oxygen saturation) in premature infants. Possible scores range from 2 (perfect stability= \> 90 %) to 0 (sever instability = any falls below 80%)
Change from baseline in heart rate on SCRIP ScoreFrom the start of SSC (0 hour) to end of SSC (2 hours) per day, assessed for three consecutive daysPossible scores range from 2 (perfect stability= regular) to 0 (sever instability = \< 80/min or\>200).
Change from baseline in respiratory rate on SCRIP ScoreFrom the start of SSC (0 hour) to end of SSC (2 hours) per day, assessed for three consecutive daysPossible scores range from 2 (perfect stability= regular) to 0 (sever instability = Apnea\> 10, Tachypnea\> 80/min, fussing/agitation
Length of sleep in minuteFrom the start of SSC (0 hour) to end of SSC (2 hours) per day, assessed for three consecutive days.length of sleep was defined by the duration between the time of closed eyes, no crying and no movement to the time that at least one of these 3 indicators is absent

Countries

Ethiopia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026